AYAlexei Yeliseev

Alexei Yeliseev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexei Yeliseev has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Lioudmila Zoubak

    National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20852, United States

    10 shared publications
  • Klaus Gawrisch

    National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20852, United States

    9 shared publications
  • Klaus Gawrisch

    †Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland

    5 shared publications
  • Tomohiro Kimura

    Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan

    4 shared publications
  • Kirk G. Hines

    NIAAA, NIH, Bethesda, MD 20892 USA

    3 shared publications
  • Krishna Vukoti

    Laboratory of Membrane Biochemistry and Biophysics NIAAA, NIH Bethesda Maryland 20892

    3 shared publications

Latest Publications

  • Open Access

    Probing the Conformational Space of the Cannabinoid Receptor 2 and a Systematic Investigation of DNP-Enhanced MAS NMR Spectroscopy of Proteins in Detergent Micelles

    by Johanna Becker-Baldus, Alexei Yeliseev, Thomas T. Joseph, Snorri Th. Sigurdsson, Lioudmila Zoubak, Kirk Hines, Malliga R. Iyer, Arjen van Den Berg, Sam Stepnowski, Jon Zmuda, et al.

    Tremendous progress has been made in determining the structures of G-protein coupled receptors (GPCR) and their complexes in recent years. However, understanding activation and signaling in GPCRs is still challenging due to the role of protein dynamics in these processes. Here, we show how dynamic nuclear polarization (DNP)-enhanced magic angle spinning nuclear magnetic resonance in combination with a unique pair labeling approach can be used to study the conformational ensemble at specific sites of the cannabinoid receptor 2. To improve the signal-to-noise, we carefully optimized the DNP sample conditions and utilized the recently introduced AsymPol-POK as a polarizing agent. We could show qualitatively that the conformational space available to the protein backbone is different in different parts of the receptor and that a site in TM7 is sensitive to the nature of the ligand, whereas a site in ICL3 always showed large conformational freedom.


  • Site-selective labeling and electron paramagnetic resonance studies of human cannabinoid receptor CB2

    by Alexei A. Yeliseev, Kaeli Zoretich, Levi Hooper, Walter Teague, Lioudmila Zoubak, Kirk G. Hines, Klaus Gawrisch


  • Recombinant Expression and Purification of Cannabinoid Receptor CB2, a G Protein-Coupled Receptor

    by Alexei A. Yeliseev

    G protein-coupled receptors (GPCR) are integral membrane proteins that regulate multiple cellular processes. To obtain insights into structural properties of GPCR and mechanism of activity, these proteins should be isolated in significant (milligram) quantities, in a pure, homogenous, and stable form. Here we describe the expression and purification of type II human cannabinoid receptor CB2, a class A GPCR, in two different types of expression hosts: in Escherichia coli and in mammalian suspension cell culture Expi293. Our method allows preparation of milligram quantities of the purified receptors suitable for a wide array of downstream applications including high-resolution structural studies and functional assays.


  • Open Access

    Cholesterol as a modulator of cannabinoid receptor CB2 signaling

    by Alexei Yeliseev, Malliga R. Iyer, Thomas T. Joseph, Nathan J. Coffey, Resat Cinar, Lioudmila Zoubak, George Kunos, Klaus Gawrisch

    Signaling through integral membrane G protein-coupled receptors (GPCRs) is influenced by lipid composition of cell membranes. By using novel high affinity ligands of human cannabinoid receptor CB2, we demonstrate that cholesterol increases basal activation levels of the receptor and alters the pharmacological categorization of these ligands. Our results revealed that (2-(6-chloro-2-((2,2,3,3-tetramethylcyclopropane-1-carbonyl)imino)benzo[d]thiazol-3(2H)-yl)ethyl acetate ligand (MRI-2646) acts as a partial agonist of CB2 in membranes devoid of cholesterol and as a neutral antagonist or a partial inverse agonist in cholesterol-containing membranes. The differential effects of a specific ligand on activation of CB2 in different types of membranes may have implications for screening of drug candidates in a search of modulators of GPCR activity. MD simulation suggests that cholesterol exerts an allosteric effect on the intracellular regions of the receptor that interact with the G-protein complex thereby altering the recruitment of G protein.


  • The C-Terminus of the mu Opioid Receptor Is Critical in G-Protein Interaction as Demonstrated by a Novel Graphene Biosensor

    by Chengyu Wen, Bernard Selling, Alexei Yeliseev, Jin Xi, Jose Manuel Perez-Aguilar, Zhaoli Gao, Jeffery G. Saven, A. T. Charlie Johnson, Renyu Liu

    Several water-soluble variants of the human mu opioid receptor (wsMORs) have been designed and expressed, which enables the detection of opioids in the nM to pM range using biosensing platforms. The tools previously developed allowed us to investigate MOR and G-protein interactions in a lipid free system to demonstrate that the lipid bilayer might not be essential for the G-protein recognition and binding. In this study, we are able to investigate G-protein interactions with MOR by using graphene enabled technology, in a lipid free system, with a high sensitivity in a real time manner. A new wsMOR with the native C-terminus was designed, expressed and then immobilized on the surfaces of scalable graphene field effect transistor (GFET)-based biosensors, enabling the recording of wsMOR/G-protein interaction with an electronic readout. G-protein only interacts with the wsMOR in the presence of the native MOR C-terminus with a K A of 32.3± 11.1 pM. The electronic readout of such interaction is highly reproducible with little variance across 50 devices in one biosensor array. For devices with receptors that do not have the native C-terminus, no significant electronic response was observed in the presence of G-protein, indicating an absence of interaction. These findings reveal that lipid environment is not essential for the G-protein interaction with MOR, however, the C-terminus of MOR is essential for G-protein recognition and high affinity binding. A system to detect MOR-G protein interaction is developed. wsMOR-G2_Cter provides a novel tool to investigate the role of C terminus in the signaling pathway.


  • Open Access

    Thermostability of a recombinant G protein-coupled receptor expressed at high level in mammalian cell culture

    by Alexei Yeliseev, Arjen van Den Berg, Lioudmila Zoubak, Kirk Hines, Sam Stepnowski, Kyle Williston, Wanhua Yan, Klaus Gawrisch, Jonathan Zmuda

    Rational design of pharmaceutical drugs targeting integral membrane G protein-coupled receptors (GPCR) requires thorough understanding of ligand binding and mechanism of activation through high resolution structural studies of purified proteins. Due to inherent conformational flexibility of GPCR, stabilization of these proteins solubilized from cell membranes into detergents is a challenging task. Here, we take advantage of naturally occurring post-translational modifications for stabilization of purified GPCR in detergent micelles. The recombinant cannabinoid CB2 receptor was expressed at high yield in Expi293F mammalian cell cultures, solubilized and purified in Façade detergent. We report superior stability of the mammalian cell-expressed receptor compared to its E.coli-expressed counterpart, due to contributions from glycosylation of the N terminus and palmitoylation of the C terminus of CB2. Finally, we demonstrate that the mammalian Expi293F amino acid labelling kit is suitable for preparation of multi-milligram quantities of high quality, selectively stable isotope-labeled GPCR for studies by nuclear magnetic resonance.


  • Open Access

    Probing thermostability of detergent-solubilized CB2 receptor by parallel G protein–activation and ligand-binding assays

    by Ryan L. Beckner, Lioudmila Zoubak, Kirk G. Hines, Klaus Gawrisch, Alexei A. Yeliseev


  • Radioligand Thermostability Assessment of Agonist-Bound Human Type 2 Cannabinoid Receptor

    by Ryan L. Beckner, Klaus Gawrisch, Alexei Yeliseev


  • Open Access

    Expression and Preparation of a G‐Protein‐Coupled Cannabinoid Receptor CB2 for NMR Structural Studies

    by Alexei Yeliseev

    Cannabinoid receptor type II, or CB2, is an integral membrane protein that belongs to a large class of G‐protein‐coupled receptors (GPCR)s. CB2 is a part of the endocannabinoid system, which plays an important role in the regulation of immune response, inflammation, and pain. Information about the structure and function of CB2 is essential for the development of specific ligands targeting this receptor. We present here a methodology for recombinant expression of CB2 and its stable isotope labeling, purification, and reconstitution into liposomes, in preparation for its characterization by nuclear magnetic resonance (NMR). Correctly folded, functional CB2 labeled with [13C,15N]tryptophan or uniformly labeled with 13C and 15N is expressed in a medium of defined composition, under controlled aeration, pH, and temperature conditions. The receptor is purified by affinity chromatography and reconstituted into lipid bilayers in the form of proteoliposomes suitable for analysis by NMR spectroscopy. © 2019 by John Wiley & Sons, Inc.


  • Simplifying G Protein-Coupled Receptor Isolation with a Calcium-Dependent Fragment Complementation Affinity System

    by Niamh Ní Mhurchú, Lioudmila Zoubak, Gavin McGauran, Sara Linse, Alexei Yeliseev, David J. O’cOnnell

    The process of isolating recombinant G protein-coupled receptors from membrane preparations is challenging requiring solubilization in detergent micelles and multi-step affinity chromatography protocols. Solubilization buffers contain high concentrations of salts, detergents and glycerol that create stringent conditions necessary to stabilize the receptor but in which affinity chromatography resins perform poorly and these resins also require the addition of eluting agents that complicate downstream assays. To simplify this process we have developed a high affinity fragment complementation molecular switch as a highly specific system for receptor capture in solubilization buffer with a calcium chelation-based elution step releasing functional protein in a simple buffer. Here we describe in detail the design, methodology, interpretation, and limitations of this novel affinity chromatography system in the isolation and purification of the cannabinoid G protein-coupled receptor CB2, in comparison with commercially available systems. This powerful tool may be applied to any recombinant membrane bound protein and can be further optimized to enhance the yield and purity of the most challenging protein targets for study.